ADIPOQ and type 2 diabetes mellitus: Animal experimental studies have shown that adiponectin exerts its effects on insulin sensitivity mainly through activating AMPK cascade or PPAR-α, which leads to a reduction in the triglyceride content in liver and muscle, thus adiponectin has been recognized as one of the strongest biomarker of type 2 diabetes in numerous studies (26, 27).